Thermo Fisher Scientific PharmacoScan

Thermo Fisher Scientific has introduced the PharmacoScan, a microarray-based research tool that contains relevant pharmacogenomic markers of the absorption, distribution, metabolism, and excretion (ADME) pathways of commonly prescribed medicines. Using PharmacoScan, researchers can interrogate more than 4,600 markers in nearly 1,200 genes involved in pharmacogenomics pathways with a single assay. The solution is enabled by the Axiom genotyping solution and automated GeneTitan multi-channel array plate processing instrument, and enables lot-to-lot reproducibility and data consistency and high-throughput and affordable sample processing. The product was developed in collaboration with the Clinical Pharmacogenetics Implementation Consortium, PharmaADME, and PharmGKB. Early-access customers include the University of Montreal Hospital Research Centre, the University of Alberta, and leading genomic service laboratories, Thermo Fisher said.